There is extensive literature on ‘beyond zero accidents’, Safety-II, and Safety Differently. However, there is a limited number of studies on the application of these concepts on a large scale. In the last few years, GSK has delivered a strong safety performance and, more recently, strived to go beyond Safety-I towards Safety-II.
Today in GSK, the safety conversations have shifted. The organisation is focused on learning deeper lessons from high-potential severity incidents, improving operational risk management, strengthening accountability for high-severity risks and measuring associated high-severity risk management maturity. GSK is committed to not only reducing the number of safety accidents but also to improving safety defences. The focus is on ensuring that things go right rather than preventing things from going wrong.
This session will outline the practical steps that GSK has taken to evolve its safety approach and present the key lessons learned from this shift.